Obio Technology Shanghai Corp Ltd
SSE:688238
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.88
12.32
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Obio Technology Shanghai Corp Ltd
Total Current Liabilities
Obio Technology Shanghai Corp Ltd
Total Current Liabilities Peer Comparison
603259
300759
2269
300347
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
O
|
Obio Technology Shanghai Corp Ltd
SSE:688238
|
Total Current Liabilities
¥314.2m
|
CAGR 3-Years
63%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Total Current Liabilities
¥13.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Total Current Liabilities
¥3.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Total Current Liabilities
¥6.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Total Current Liabilities
¥5.3B
|
CAGR 3-Years
54%
|
CAGR 5-Years
28%
|
CAGR 10-Years
48%
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Total Current Liabilities
¥1.3B
|
CAGR 3-Years
241%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Obio Technology Shanghai Corp Ltd's Total Current Liabilities?
Total Current Liabilities
314.2m
CNY
Based on the financial report for Dec 31, 2023, Obio Technology Shanghai Corp Ltd's Total Current Liabilities amounts to 314.2m CNY.
What is Obio Technology Shanghai Corp Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
32%
Over the last year, the Total Current Liabilities growth was 68%. The average annual Total Current Liabilities growth rates for Obio Technology Shanghai Corp Ltd have been 63% over the past three years , 32% over the past five years .
You don't have any saved screeners yet
